
Limited RCTs exist for ME/CFS biomarkers; most from case-control studies. Related abnormalities: 1. RABGAP1L (infection response): Persistent EBV/HHV-6 markers (Brenu 2013). 2. BTN2A2 (T-cell immunity): T-cell exhaustion (Mandarano 2024). 3. FBXL4 (mito DNA): Impaired ATP production (Tomas 2017). 4. SUDS3 (microglial inflammation): Elevated neuroinflammation (Nakatomi 2014 PET). 5. OLFM4 (neutrophil responses): Increased neutrophil apoptosis (Kennedy 2004). 6. CCPG1 (ER stress/autophagy): ER stress markers (Nguyen 2019). 7. CA10 (synaptic/pain): Central sensitization (Nijs 2012 review). 8. ARFGEF2/CSE1L (inflammation): Raised TNF-α/IL-6 (Maes 2012).















